Cargando…
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer
Tumor-associated macrophages (TAMs) enhance tumor growth in mice and are correlated with a worse prognosis for breast cancer patients. While early therapies sought to deplete all macrophages, current therapeutics aim to reprogram pro-tumor macrophages (M2) and preserve those necessary for anti-tumor...
Autores principales: | Esser, Alison K., Ross, Michael H., Fontana, Francesca, Su, Xinming, Gabay, Ariel, Fox, Gregory C., Xu, Yalin, Xiang, Jingyu, Schmieder, Anne H., Yang, Xiaoxia, Cui, Grace, Scott, Michael, Achilefu, Samuel, Chauhan, Jay, Fletcher, Steven, Lanza, Gregory M., Weilbaecher, Katherine N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359087/ https://www.ncbi.nlm.nih.gov/pubmed/32685002 http://dx.doi.org/10.7150/thno.44523 |
Ejemplares similares
-
Fumagillin Prodrug Nanotherapy Suppresses Macrophage Inflammatory Response via Endothelial Nitric Oxide
por: Zhou, Hui-fang, et al.
Publicado: (2014) -
Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment
por: Malekghasemi, Somaiyeh, et al.
Publicado: (2020) -
Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes
por: Komohara, Yoshihiro, et al.
Publicado: (2023) -
An acid trip activates protumoral macrophages to promote hepatocellular carcinoma malignancy
por: Graham, Nicola, et al.
Publicado: (2022) -
Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics
por: Rabold, Katrin, et al.
Publicado: (2020)